UBS Maintains Neutral on IDEXX Laboratories, Lowers Price Target to $627

Benzinga · 3d ago
UBS analyst Andrea Alfonso maintains IDEXX Laboratories (NASDAQ:IDXX) with a Neutral and lowers the price target from $670 to $627.